Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $288M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MPLT | MAPLIGHT THERAPEUTICS INC | 950,011 | $34.05M | 11.8% | — | — | COM | 56565P103 |
| TYRA | TYRA BIOSCIENCES INC | 1,029,298 | $32.88M | 11.4% | — | — | COM | 90240B106 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,056,379 | $29.85M | 10.4% | — | — | COM | 29384C108 |
| PHVS | PHARVARIS N V | 797,600 | $27.58M | 9.6% | — | — | COM | N69605108 |
| CAMP | CAMP4 THERAPEUTICS CORP | 5,869,091 | $25.65M | 8.9% | — | — | COM | 13463J101 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $22.83M | 7.9% | — | — | COM | 04317A107 |
| TECX | TECTONIC THERAPEUTIC INC | 606,660 | $20.85M | 7.2% | — | — | COM | 878972108 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3,947,913 | $19.15M | 6.7% | — | — | COM | 98943L107 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 497,270 | $18.5M | 6.4% | — | — | COM NEW | 15117B202 |
| EYPT | EYEPOINT INC | 1,050,000 | $15.02M | 5.2% | — | — | COM NEW | 30233G209 |
| BHVN | BIOHAVEN LTD | 738,972 | $11M | 3.8% | — | — | COM | G1110E107 |
| SRZN | SURROZEN INC | 271,250 | $7.039M | 2.4% | — | — | COM NEW | 86889P208 |
| SKYE | SKYE BIOSCIENCE INC | 9,681,763 | $6.712M | 2.3% | — | — | COM NEW | 83086J200 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,057,325 | $6.329M | 2.2% | — | — | COM | 00166B105 |
| TARA | PROTARA THERAPEUTICS INC | 1,369,782 | $5.233M | 1.8% | — | — | COM STK | 74365U107 |
| SLN | SILENCE THERAPEUTICS PLC | 476,200 | $5.229M | 1.8% | — | — | ADS | 82686Q101 |